Education
About Us
Working with TipRanks
Follow Us
Andrew G Long Insider Profile
4 Followers
Andrew G Long, CEO, Director at Insys Therapeutics, holds 285.63K shares in Owens & Minor (Ticker: OMI), holds 62.08K shares in Insys Therapeutics (Ticker: INSYQ).
Andrew G Long Insys Therapeutics (INSYQ)CEO, Director
Insys Therapeutics (INSYQ)
CEO, Director
Not Ranked
Andrew G Long has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP, CEO P&HS
Roles that Andrew G Long holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Andrew G Long
Andrew G Long's Trading History
Insys Therapeutics
Jun 05, 2019
―
Uninformative Buy
―
$2.61K
Owens & Minor
Mar 05, 2025
EVP, CEO P&HS
Uninformative Buy
―
$2.86M
List of latest transactions for each holding click on a transaction to see Andrew G Long's performance on stock
You May Also Like
Andrew G Long insider profile FAQ
What is the percentage of profitable transactions made by Andrew G Long?
The percentage of profitable transactions made by Andrew G Long is ―.
What is the average return per transaction made by Andrew G Long?
The average return per transaction made by Andrew G Long is ―.
What stocks does Andrew G Long hold?
Andrew G Long holds: INSYQ, OMI stocks.
What was Andrew G Long’s latest transaction?
Andrew G Long latest transaction was an Uninformative Buy of ―.
What was Andrew G Long's most profitable transaction?
Andrew G Long’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andrew G Long's role in Insys Therapeutics?
Andrew G Long's role in Insys Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.